Commonwealth Equity Services LLC decreased its position in Accenture PLC (NYSE:ACN – Free Report) by 30.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 138,219 shares of the information technology services provider’s stock after selling 61,388 shares during the period. Commonwealth Equity Services LLC’s holdings in Accenture were worth $34,085,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in ACN. Brighton Jones LLC grew its position in shares of Accenture by 36.2% in the fourth quarter. Brighton Jones LLC now owns 18,438 shares of the information technology services provider’s stock valued at $6,486,000 after purchasing an additional 4,905 shares during the last quarter. SCS Capital Management LLC acquired a new stake in Accenture during the 1st quarter valued at $1,827,000. Advisory Alpha LLC increased its position in Accenture by 15.7% during the first quarter. Advisory Alpha LLC now owns 1,778 shares of the information technology services provider’s stock worth $555,000 after buying an additional 241 shares in the last quarter. SageView Advisory Group LLC raised its holdings in shares of Accenture by 12.6% in the first quarter. SageView Advisory Group LLC now owns 2,736 shares of the information technology services provider’s stock worth $854,000 after acquiring an additional 307 shares during the last quarter. Finally, Ilmarinen Mutual Pension Insurance Co lifted its position in shares of Accenture by 7.9% in the first quarter. Ilmarinen Mutual Pension Insurance Co now owns 102,500 shares of the information technology services provider’s stock valued at $31,984,000 after acquiring an additional 7,500 shares in the last quarter. 75.14% of the stock is currently owned by hedge funds and other institutional investors.
Accenture Stock Down 0.7%
Shares of ACN opened at $274.00 on Thursday. Accenture PLC has a fifty-two week low of $229.40 and a fifty-two week high of $398.35. The company’s fifty day moving average is $259.04 and its two-hundred day moving average is $259.82. The firm has a market cap of $168.68 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 2.66 and a beta of 1.25. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.16.
Accenture Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Tuesday, January 13th will be given a dividend of $1.63 per share. This represents a $6.52 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, January 13th. Accenture’s dividend payout ratio is 53.88%.
Insider Transactions at Accenture
In other Accenture news, CEO Julie Spellman Sweet sold 9,000 shares of Accenture stock in a transaction that occurred on Wednesday, October 22nd. The shares were sold at an average price of $249.57, for a total transaction of $2,246,130.00. Following the transaction, the chief executive officer directly owned 23,516 shares of the company’s stock, valued at $5,868,888.12. The trade was a 27.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Ryoji Sekido sold 2,500 shares of the stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $249.47, for a total transaction of $623,675.00. Following the completion of the sale, the chief executive officer directly owned 1,390 shares of the company’s stock, valued at $346,763.30. The trade was a 64.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 35,151 shares of company stock valued at $8,841,525 in the last three months. 0.02% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on ACN shares. Guggenheim boosted their target price on shares of Accenture from $285.00 to $305.00 and gave the company a “buy” rating in a research note on Monday, December 15th. Royal Bank Of Canada set a $300.00 price objective on shares of Accenture in a research report on Thursday, December 18th. Susquehanna upped their price objective on shares of Accenture from $270.00 to $277.00 and gave the company a “neutral” rating in a research note on Friday, December 19th. Wells Fargo & Company initiated coverage on shares of Accenture in a research note on Tuesday, October 21st. They issued an “equal weight” rating and a $251.00 target price for the company. Finally, Robert W. Baird reduced their price target on Accenture from $350.00 to $330.00 and set an “outperform” rating on the stock in a research note on Friday, September 26th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $295.84.
Check Out Our Latest Stock Analysis on ACN
Key Accenture News
Here are the key news stories impacting Accenture this week:
- Positive Sentiment: Truist began coverage on ACN with a “buy” and $317 price target, giving the stock visible analyst backing and implying meaningful upside. Accenture (ACN) Has a New Rating from Truist Financial
- Positive Sentiment: Accenture agreed to acquire Faculty, an AI-native services/products firm — a deal that expands its GenAI capabilities and go‑to‑market for client AI transformations. This is a strategic revenue-growth catalyst. Accenture to Acquire Faculty to Scale AI Capabilities
- Positive Sentiment: Partnership with NTT DOCOMO GLOBAL to build Universal Wallet Infrastructure showcases Accenture’s positioning in large data-led, identity and digital‑trust initiatives — another strategic growth opportunity. NTT DOCOMO GLOBAL and Accenture Launch Universal Wallet Infrastructure
- Neutral Sentiment: Coverage and valuation pieces are taking stock of the AI M&A and partnerships — useful context for investors but not an immediate catalyst on their own. Assessing Accenture (ACN) Valuation After New AI Acquisition And Digital Trust Partnership
- Neutral Sentiment: Rothschild & Co Redburn adjusted its price target (low relative to the stock) and maintained neutral — a reminder that some analysts remain cautious about near‑term upside. Rothschild & Co Redburn adjusts PT
- Negative Sentiment: Coverage flagged softer public‑sector demand, which could pressure consulting revenue in the near term and weigh on sentiment for a material part of Accenture’s business. Is Softer Public-Sector Demand Undermining the Resilience of Accenture’s Consulting Engine?
- Negative Sentiment: Insider selling: CEO Mauro Macchi sold 500 shares and General Counsel Joel Unruch sold 1,332 shares in early January. Sizeable insiders remain invested, but these disclosed sales can create short‑term negative optics. SEC Filing – CEO Sale SEC Filing – GC Sale
Accenture Company Profile
Accenture is a global professional services company that provides a broad range of services and solutions in strategy, consulting, digital, technology and operations. The firm works with organizations across industries to design and implement business transformation programs, deploy and manage enterprise technology, optimize operations, and develop customer and digital experiences. Its offerings encompass management and technology consulting, systems integration, application and infrastructure services, cloud migration and managed services, as well as security and analytics capabilities.
The company delivers industry- and function-specific solutions, combining consulting expertise with proprietary tools, platforms and partnerships with major technology vendors.
See Also
- Five stocks we like better than Accenture
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
